Search clinical trials for: Durvalumab doxorubicin cobination
Total 7576 results
-
Yonsei UniversityActive, not recruitingSarcomaKorea, Republic of
-
Wuhan Union Hospital, ChinaUnknownSmall Cell Lung Cancer | Anlotinib | Durvalumab
-
French Innovative Leukemia OrganisationCompleted
-
Seoul National University HospitalActive, not recruitingCarcinoma, Non-Small-Cell LungKorea, Republic of
-
AstraZenecaActive, not recruitingPediatric Cancer | Hematological Malignancies | Solid Tumor PediatricSpain, Italy, United States, United Kingdom, France, Netherlands, Germany
-
AIO-Studien-gGmbHAstraZenecaWithdrawn
-
Yonsei UniversitySamsung Medical Center; AstraZeneca; Seoul National University Hospital; Korean... and other collaboratorsRecruitingPlatinum-resistant Recurrent Ovarian CancerKorea, Republic of
-
ADC Therapeutics S.A.TerminatedFollicular Lymphoma | Diffuse Large B-Cell Lymphoma | Mantle Cell LymphomaSpain, United States
-
Alaunos TherapeuticsCompletedSoft Tissue SarcomaUnited States, France, Spain, Belgium, Argentina, Colombia, Israel, India, Romania, Australia, Canada, Singapore, Russian Federation, Brazil, Chile, Germany, Guatemala, Italy, Panama, Poland, United Kingdom
-
AIO-Studien-gGmbHAstraZenecaCompletedRecurrent Adult Soft Tissue Sarcoma | Metastatic Adult Soft Tissue SarcomaGermany
-
University of Colorado, DenverWithdrawn
-
AstraZenecaICON plcRecruitingHepatobiliary CancersUnited States, Greece, Puerto Rico, Germany, Italy, France
-
University of NebraskaAstraZenecaTerminatedSmall Cell Lung CarcinomaUnited States
-
Mridula George, MDRecruitingOCTANE: Adjuvant Liposomal Doxorubicin and Carboplatin for Early-stage Triple-negative Breast CancerTriple Negative Breast Cancer (TNBC)United States
-
Institut BergoniéAstraZeneca; PharmaMarCompletedSoft Tissue Sarcoma | Ovarian CarcinomaFrance
-
Ludwig Institute for Cancer ResearchCelgene; Cancer Research Institute, New York City; MedImmune LLCCompletedOvarian CancerUnited States, Switzerland
-
National Cancer Institute (NCI)RecruitingHepatocellular Carcinoma | Hepatocellular Cancer | Metastatic Hepatocellular CarcinomaUnited States
-
Threshold PharmaceuticalsSarcoma Alliance for Research through Collaboration (SARC)CompletedSoft Tissue SarcomaUnited States, France, Canada, Spain, Germany, Belgium, Poland, Austria, Denmark, Hungary, Israel, Italy, Russian Federation
-
AstraZenecaRecruitingAdv Solid Malig - H&N SCC, ATM Pro / Def NSCLC, Gastric, Breast and Ovarian CancerSpain, United States, Belgium, United Kingdom, France, Hungary, Canada, Korea, Republic of, Australia
-
SanofiCompletedBreast NeoplasmsSpain, Italy, Australia, Czech Republic, Germany, Hungary, Ireland, Israel, New Zealand, Portugal, Slovenia, Slovakia, Austria, Sweden, United Kingdom, Belgium, Brazil, Chile, Denmark, South Africa, Switzerland
-
University of RegensburgEssex Pharma GermanyCompleted
-
University of Alabama at BirminghamTerminatedCholangiocarcinomaUnited States
-
Philogen S.p.A.TerminatedBreast Cancer | Advanced Solid TumorItaly
-
Duke UniversityAstraZenecaCompletedTriple Negative Breast CancerUnited States
-
TelikCompletedOvarian NeoplasmsUnited States
-
Lahey ClinicVarian Medical SystemsCompletedHCC | Hepatocellular CarcinomaUnited States
-
Lahey ClinicVarian Medical Systems; Merit Medical Systems, Inc.Active, not recruitingHCC | Hepatocellular CarcinomaUnited States, Canada
-
AstraZenecaKappa SantéRecruiting
-
Yonsei UniversityRecruitingPotentially Resectable Stage II/IIIa NSCLCKorea, Republic of
-
Centre Leon BerardCompletedFRAIL-IMMUNE (GORTEC 2018-03) - Combination of Durvalumab With Carboplatin/Paclitaxel (FRAIL-IMMUNE)Squamous Cell Carcinoma of the Head and NeckFrance
-
MedImmune LLCCompletedStage III Non-small Cell Lung Cancer | UnresectableUnited States, Canada, Italy, Spain, France, Hong Kong, Portugal, Taiwan, Poland
-
AstraZenecaActive, not recruitingBreast CancerUnited States, Belgium, Italy, Spain, United Kingdom, Germany, Austria, Israel, Australia
-
Academic Thoracic Oncology Medical Investigators...AstraZenecaCompletedNon-Small Cell Lung Cancer NSCLCUnited States
-
Yonsei UniversityCompleted
-
NSABP Foundation IncCompletedRectal CancerUnited States
-
Hark Kyun KimRecruiting
-
Oslo University HospitalAstraZenecaActive, not recruitingCancer | NSCLC | Non Small Cell Lung Cancer | NSCLC, Stage III | Non Small Cell Lung Cancer Stage IIINorway, Finland, Lithuania, Estonia
-
MedImmune LLCCompletedAdvanced Solid TumorsUnited States, France, Spain, Switzerland
-
Grupo Espanol Multidisciplinario del Cancer DigestivoAstraZeneca; Vall d'Hebron Institute of Oncology (VHIO)Recruiting
-
Institut Cancerologie de l'OuestAstraZenecaActive, not recruitingBone Metastases | Prostate Cancer Patients | Node; ProstateFrance
-
AstraZenecaCompleted
-
University of Texas Southwestern Medical CenterAstraZenecaActive, not recruitingNon Small Cell Lung Cancer | Lung Cancer Stage IIIUnited States
-
Yonsei UniversityNot yet recruitingNon Small Cell Lung CancerKorea, Republic of
-
Biocity Biopharmaceutics Co., Ltd.Not yet recruitingHepatocellular CarcinomaChina
-
Memorial Sloan Kettering Cancer CenterAstraZeneca; MedImmune LLCActive, not recruiting
-
Canadian Cancer Trials GroupAstraZenecaActive, not recruiting
-
AstraZenecaCompletedSmall Cell Lung Carcinoma Extensive DiseaseChina
-
Assistance Publique - Hôpitaux de ParisAstraZenecaRecruitingBCLC A Hepatocellular Carcinoma Non-resectable and Not Amenable for RFAFrance
-
ETOP IBCSG Partners FoundationAstraZeneca AG SwitzerlandNot yet recruiting
-
AstraZenecaActive, not recruiting